IRIS
ZAPPAVIGNA, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.298
NA - Nord America 2.092
AS - Asia 356
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 4
OC - Oceania 3
AF - Africa 1
Totale 4.758
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.084
IE - Irlanda 797
IT - Italia 504
GB - Regno Unito 226
UA - Ucraina 225
DE - Germania 153
FR - Francia 105
CN - Cina 100
SG - Singapore 100
SE - Svezia 86
FI - Finlandia 79
GR - Grecia 69
VN - Vietnam 54
TR - Turchia 41
BE - Belgio 19
KR - Corea 19
PK - Pakistan 10
IN - India 9
NL - Olanda 9
CA - Canada 8
IR - Iran 7
PL - Polonia 7
JP - Giappone 6
CZ - Repubblica Ceca 5
BR - Brasile 4
EU - Europa 4
TW - Taiwan 4
AU - Australia 3
PH - Filippine 3
RU - Federazione Russa 3
AT - Austria 2
CH - Svizzera 2
DK - Danimarca 2
BG - Bulgaria 1
EE - Estonia 1
ES - Italia 1
HK - Hong Kong 1
IL - Israele 1
KE - Kenya 1
MD - Moldavia 1
RS - Serbia 1
SY - Repubblica araba siriana 1
Totale 4.758
Salva come PNG Salva come JPEG
Città #
Dublin 797
Chandler 517
Jacksonville 363
Caserta 98
Princeton 96
Roxbury 83
New York 79
Medford 73
Boardman 58
Bremen 58
Naples 57
Singapore 57
Ann Arbor 54
Dong Ket 54
Des Moines 35
Cambridge 33
Wilmington 33
Napoli 31
Beijing 29
Woodbridge 25
Mountain View 24
Helsinki 22
San Mateo 22
Ashburn 21
Aversa 20
Los Angeles 19
Brussels 18
Milan 15
Rome 12
Campodarsego 11
San Nicola la Strada 10
Seoul 10
San Felice A Cancello 9
Jinan 8
Munich 8
Elora 7
Houston 7
Nanjing 7
Redwood City 7
Xi'an 7
Düsseldorf 6
Seregno 6
Auburn Hills 5
Brno 5
Lissone 5
Ningbo 5
Norwalk 5
Scafati 5
Bahawalpur 4
Berlin 4
Changsha 4
Delhi 4
Guangzhou 4
Lappeenranta 4
Taipei 4
Tianjin 4
Torre Annunziata 4
Amsterdam 3
Bologna 3
Frankfurt am Main 3
Groningen 3
Hebei 3
Panettieri 3
Quezon City 3
San Giorgio a Cremano 3
Scandiano 3
Seattle 3
Shenyang 3
Siena 3
Taiyuan 3
Amantea 2
Cagliari 2
Capannori 2
Chicago 2
Clifton 2
Cosenza 2
Dearborn 2
Fairfield 2
Florence 2
Frattaminore 2
Freigericht 2
Genova 2
Gragnano 2
Haikou 2
Hyderabad 2
Kunming 2
Nanchang 2
Nuremberg 2
Parma 2
Pomigliano d'Arco 2
Portici 2
Salerno 2
Sassari 2
Sydney 2
Taunsa 2
Terzigno 2
Tricase 2
Udine 2
Urbino 2
Vertova 2
Totale 3.071
Salva come PNG Salva come JPEG
Nome #
Espressione del recettore dell’urotensina-II nell’adenocarcinoma del colon umano: studi in vitro ed in vivo. 101
Valutazione in vitro degli effetti cardiotossici da 5-Fluorouracile per la prevenzione dei danni cardiovascolari negli operatori sanitari professionalmente esposti. [Evaluation in vitro of the cardiotoxic effects of 5-fluorouracil for the prevention of cardiovascular damage in health workers occupationally exposed]. 100
NANOPARTICELLE FUNZIONALIZZATE CON TRANSFERRINA ED INCAPSULANTI ACIDO ZOLEDRONICO DETERMINANO INIBIZIONE DELLA CRESCITA DEL GLIOBLASTOMA INTRACRANICO IN VIVO 88
The 1,4 benzoquinone-featured 5-lipoxygenase inhibitor RF-Id induces apoptotic death through downregulation of IAPs in human glioblastoma cells 86
MicroRNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib 85
Effect of restriction vegan diet's on muscle mass, oxidative status, and myocytes differentiation: A pilot study 81
Dicrocoelium dendriticum induces autophagic vacuoles accumulation in human hepatocarcinoma cells 79
5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress. 73
Stealth liposomes encapsulating zoledronic acid: a new opportunity to treat neuropathic pain. 73
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment 71
Mitochondria as playmakers of apoptosis, autophagy and senescence 71
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells 70
Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells 68
Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-α activation 67
Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC. 67
The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell lines. 65
Emerging strategies to strengthen the anti-tumour activity of type I IFNs: overcoming survival pathways 65
Urotensin-II receptor expression in human colon adenocarcinoma: in vitro and in vivo studies. 65
A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives. 64
Prognostic value of EGFR and EGFR-MEDIATED transduction signal inhibition: effective therapeutic strategies in the management of laryngeal cancer 64
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 63
Transferrin-targeted nanoparticles containing zoledronic acid as a potential to inhibit glioblastoma growth 63
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion. 61
Silybin–Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress 61
Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells 60
Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers. 60
Aggressiveness pattern and second primary tumor risk associated with basaloid squamous cell carcinoma of the larynx 60
Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures 60
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms 58
Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev) 58
Erlotinib: early clinical development in brain cancer. 56
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 56
Emerging pathways as individualized therapeutic target of multiple myeloma. 55
Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid. 54
Bovine serum amine oxidase and spm potentiate docetaxel and interferon-alpha effects in inducing apoptosis on human cancer cells through the generation of oxidative stress. 54
MicroRNA-125a-5p Is a Downstream Effector of Sorafenib in Its Antiproliferative Activity Toward Human Hepatocellular Carcinoma Cells 54
A hydroquinone-based derivative elicits apoptosis and autophagy via activating a ros-dependent unfolded protein response in human glioblastoma 54
Il recettore dell’ urotensina: un nuovo marker per il differenziamento ed il target nel cancro del colon? 53
Interleukin 18: Friend or foe in cancer. 53
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 52
Zoledronic acid encapsulated in self-assembly pegylated nanoparticles as a new delivery system against brain tumors 52
UROTENSIN II RECEPTOR IS INVOLVED IN THE REGULATION OF MOTILITY OF PROSTATE ADENOCARCINOMA CELLS AND PREDICTS THE CLINICAL OUTCOME OF PROSTATE CANCER PATIENTS 52
Measurement of autophagy by flow cytometry 52
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 51
Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistance. 50
Drug-drug interactions based on pharmacogenetic profile between highly active antiretroviral therapy and antiblastic chemotherapy in cancer patients with HIV infection 50
Anti-inflammatory drugs as anticancer agents 50
Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells. 49
MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer 49
Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes. 48
Zoledronic acid delivered by self-assembly pegylated nanoparticles has antitumor efficacy against glioblastoma cell lines and xenografts 48
Liposome armed with herpes virus-derived gH625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell lines 47
Long non-coding RNAs as important biomarkers in laryngeal cancer and other head and neck tumours 47
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study. 46
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism. 44
Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses 44
Combined treatment with PPAR-γ agonists in pancreatic cancer: a glimmer of hope for cancer therapy? 43
CYR61 DOWN-MODULATION SENSITIZES PROSTATE CANCER CELLS TO ZOLEDRONIC ACID AND DOCETAXEL: A NEW ANTICANCER STRATEGY 43
Self-assembly nanoparticles for the delivery of bisphosphonates into tumors. 42
Levofolene modulates apoptosis induced by 5-fluorouracil through autophagy inhibition: Clinical and occupational implications 42
Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells. 42
Ipilimumab for the treatment of metastatic prostate cancer 42
Peptide functionalization of silicon for detection and classification of prostatic cells 42
Testicular cancer from diagnosis to epigenetic factors 41
Insight toward the microRNA profiling of laryngeal cancers: Biological role and clinical impact 41
LncRNAs and Immunity: Coding the Immune System with Noncoding Oligonucleotides. 41
Chitosan-based polyelectrolyte complexes for doxorubicin and zoledronic acid combined therapy to overcome multidrug resistance 41
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide 41
Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem 41
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors 39
Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade 39
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 38
Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells 37
The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells. 37
CYR61 down-modulation induced by zoledronic acid impairs cell motility and sensitizes prostate cancer cells to docetaxel: A new anti-cancer strategy 37
Molecular and preclinical models enhancing anti-tumour activity of zoledronic acid 36
Nanotechnologies to use zoledronic acid as a potent antitumoral agent 36
Autophagic cell death: A new frontier in cancer research 36
Molecular markers as a new tool for diagnostic and prognostic definition of type 2 diabetes mellitus 35
The role of micrornas in development of colitis-associated colorectal cancer 35
Hepatocarcinoma: genetic and epigenetic features 34
Non-coding RNAs as a new dawn in tumor diagnosis 34
In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role? 34
Long non-coding RNAs in cancer stem cells 34
Extracellular Vesicles: New Endogenous Shuttles for miRNAs in Cancer Diagnosis and Therapy? 33
Protein kinase a detection in human urine samples 32
Stealth liposomes for the delivery of zoledronic acid into tumors enhance the anticancer activity of the drug 31
Possible Effects of Uremic Toxins p-Cresol, Indoxyl Sulfate, p-Cresyl Sulfate on the Development and Progression of Colon Cancer in Patients with Chronic Renal Failure 31
The stress hormone norepinephrine increases migration of prostate cancer cells in vitro and in vivo 30
Nanoparticles releasing zoledronic acid have antitumor activity against experimental models of human glioblastoma 29
Prognostic role of translocator protein and oxidative stress markers in chronic lymphocytic leukemia patients treated with bendamustine plus rituximab. 28
ZOLEDRONIC ACID INCREASES THE EXPRESSION OF NDRG1 GENE IN HUMAN ANDROGEN-INDEPENDENT PROSTATE CANCER PC3 CELLS 28
MicroRNA-nanoparticles against cancer: Opportunities and challenges for personalized medicine 28
Immunotherapy of colorectal cancer: New perspectives after a long path 26
A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells 25
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer 22
Hybrid lipid self-assembling nanoparticles for brain delivery of microRNA. 22
Molecular Characterization of Cancer Associated Fibroblasts in Prostate Cancer 20
Metastatic colorectal cancer and type 2 diabetes: prognostic and genetic interactions 19
OVERVIEW OF FDA-APPROVED ANTI CANCER DRUGS USED FOR TARGETED THERAPY 18
Totale 4.932
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.913
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.913
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020338 0 0 13 20 68 18 98 38 36 19 21 7
2020/2021667 38 8 56 32 101 27 84 50 51 67 83 70
2021/2022688 24 11 11 12 206 11 15 22 30 89 50 207
2022/20231.710 155 49 29 193 149 163 3 106 750 23 55 35
2023/2024740 72 32 54 37 202 93 19 20 12 5 51 143
2024/202563 17 46 0 0 0 0 0 0 0 0 0 0
Totale 5.094